BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34032720)

  • 1. Prognostic value of metabolic parameters measured by pretreatment dual-time-point 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with intrahepatic or perihilar cholangiocarcinoma: A STROBE study.
    Hwang JP; Moon JH; Kim HK; Lee MH; Lim CH; Park SB; Yoon JK; Park JM
    Medicine (Baltimore); 2021 May; 100(21):e26015. PubMed ID: 34032720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary tumor maximum standardized uptake value measured on 18F-fluorodeoxyglucose positron emission tomography-computed tomography is a prognostic value for survival in bile duct and gallbladder cancer.
    Lee JY; Kim HJ; Yim SH; Shin DS; Yu JH; Ju DY; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2013 Oct; 62(4):227-33. PubMed ID: 24162710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
    Hwang JP; Lim I; Byun BH; Kim BI; Choi CW; Lim SM
    Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer.
    Park MS; Lee SM
    Anticancer Res; 2014 May; 34(5):2551-4. PubMed ID: 24778075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy.
    Conrad GR; Sinha P
    Nucl Med Commun; 2003 Nov; 24(11):1129-37. PubMed ID: 14569166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.
    Cokmert S; Tanriverdi O; Karapolat I; Demir L; Bayoglu V; Can A; Akyol M; Yilmaz Y; Oktay Tarhan M
    J BUON; 2016; 21(6):1410-1418. PubMed ID: 28039701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The maximum standardized uptake value increment calculated by dual-time-point
    Yonezawa N; Minamikawa T; Kitajima K; Takahashi Y; Sasaki R; Nibu KI; Komori T
    Nagoya J Med Sci; 2017 Feb; 79(2):189-198. PubMed ID: 28626254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of
    Xian WJ; Feng YL; Wang Y; Yang M; Lu SN
    Br J Radiol; 2022 Jan; 95(1129):20210279. PubMed ID: 34813375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between TNM staging of primary cholangiocarcinoma and the maximum standard uptake value of (18)F-2-deoxy-D-glucose positron emission tomography with computerized tomography].
    Wang ZF; Lan XL; Xiao YR; Liu JP; Ji JS
    Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(39):3104-3107. PubMed ID: 29081157
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.
    Ruys AT; Bennink RJ; van Westreenen HL; Engelbrecht MR; Busch OR; Gouma DJ; van Gulik TM
    HPB (Oxford); 2011 Apr; 13(4):256-62. PubMed ID: 21418131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of metabolic 18F-FDG PET/CT parameters and hematological prognostic indicators in patients with colorectal cancer.
    Cengiz A; Yersal Ö; Ömürlü İK; Yürekli Y
    Indian J Cancer; 2023; 60(2):224-229. PubMed ID: 37530245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma.
    Hwang JP; Lim I; Kong CB; Jeon DG; Byun BH; Kim BI; Choi CW; Lim SM
    PLoS One; 2016; 11(4):e0153281. PubMed ID: 27100297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance and Prognostic Relevance of FDG Positron Emission Tomography/Computed Tomography for Patients with Extrahepatic Cholangiocarcinoma.
    Kim NH; Lee SR; Kim YH; Kim HJ
    Korean J Radiol; 2020 Dec; 21(12):1355-1366. PubMed ID: 32767862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of preoperative fluorodeoxyglucose positron emission tomography/computed tomography in patients with potentially resectable pancreatic cancer.
    Omiya Y; Ichikawa S; Satoh Y; Motosugi U; Nakajima N; Onishi H
    Abdom Radiol (NY); 2018 Dec; 43(12):3381-3389. PubMed ID: 30043215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Percentage Change in Metabolic Parameters as Measured by Dual-Time Point
    Yoo J; Yoon HJ; Kim BS
    J Womens Health (Larchmt); 2017 Oct; 26(10):1131-1137. PubMed ID: 28498790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of Prognostic Impact of Tumor SUVmax by
    Yoh T; Seo S; Morino K; Fuji H; Ikeno Y; Ishii T; Taura K; Nakamoto Y; Higashi T; Kaido T; Uemoto S
    World J Surg; 2019 May; 43(5):1323-1331. PubMed ID: 30680501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma.
    Feng X; Wen X; Li L; Sun Z; Li X; Zhang L; Wu J; Fu X; Wang X; Yu H; Ma X; Zhang X; Xie X; Han X; Zhang M
    Cancer Res Treat; 2021 Jul; 53(3):837-846. PubMed ID: 33285054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.